Preterm Birth
Related entities
Findings (50)
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineCervical cancer survivors had a substantially higher risk of preterm birth in their first live singleton birth conceived after diagnosis, with 28% of births delivered before 37 weeks compared to match
Effect: decline; RR=2.8; CI: 95% CI: 2.1, 3.7
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5
None
declineLeukemia survivors had a higher risk of preterm birth and low birth weight in their first live singleton birth conceived after diagnosis.
Effect: decline; RR=2.1; CI: 95% CI: 1.3, 3.5